Blackwell Publishing has issued a set of guidelines for its journal editors in order to increase transparency and smoke out conflicts of interest. They advise their editors to make sure that authors describe their contributions to the research project in order to lessen the frequency of ghost authorship and honorary authorship.
They also mention that duplicate publication is a no-no and insist that editors be free of influence from business managers. Consider the following situation: Both a journal editor and the journal’s business manager are aware that a clinical trial (well-designed or not) can bring in beaucoup bucks in reprints (to be distributed to docs by drug reps) whereas another study, that may be more scientifically sound, may yield zilch in reprint income. Financially, the choice is obvious, but the scientific choice may yield an opposite conclusion. I thank Richard Smith as well as Lexchin and Light for bringing the issue of journal reprints to the fore.
Nonetheless, I commend Blackwell for their effort. It's a good step. Kudos.
Please read the whole story at Inside Higher Education. There’s much more to it than I’ve written in this post.
No comments:
Post a Comment